ViroPharma (VPHM)
Add to Watchlists Create an Alert
26.44
+0.34 +1.30%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
ViroPharma Accounts Receivable:
58.39M for March 31, 2013ViroPharma Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 58.39M |
| Dec. 31, 2012 | 74.40M |
| Sept. 30, 2012 | 51.06M |
| June 30, 2012 | 54.61M |
| March 31, 2012 | 63.39M |
| Dec. 31, 2011 | 78.53M |
| Sept. 30, 2011 | 69.37M |
| June 30, 2011 | 68.68M |
| March 31, 2011 | 59.72M |
| Dec. 31, 2010 | 43.88M |
| Sept. 30, 2010 | 54.02M |
| June 30, 2010 | 48.42M |
| March 31, 2010 | 47.25M |
| Dec. 31, 2009 | 41.24M |
| Sept. 30, 2009 | 38.63M |
| June 30, 2009 | 33.04M |
| March 31, 2009 | 27.40M |
| Dec. 31, 2008 | 15.06M |
| Sept. 30, 2008 | 22.92M |
| June 30, 2008 | 27.22M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
VPHM Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Halozyme Therapeutics | 15.70M |
| Incyte | 28.04M |
| Optimer Pharmaceuticals | 9.510M |
VPHM Accounts Receivable Rankings
| Overall |
78th percentile 1745 of 8009 |
| Sector |
79th percentile 140 of 687 in Healthcare |
| Industry |
92nd percentile 19 of 248 in Biotechnology |
VPHM Accounts Receivable Range, Past 5 Years
| Minimum | 15.06M | Dec 2008 |
| Maximum | 78.53M | Dec 2011 |
| Average | 48.86M |